Human eosinophils express a receptor for secretory component. Role in secretory IgA‐dependent activation
- 1 January 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (1) , 117-125
- https://doi.org/10.1002/eji.1830250121
Abstract
The existence of a functional receptor for secretory component (SC) on the eosinophil membrane might explain the preferential degranulation induced by secretory IgA (sIgA) when compared to serum IgA. Indeed, flow cytometry analysis revealed that purified human SC could bind to a subpopulation (4–59%) of blood eosinophils purified from 19 patients with eosinophilia. Binding of radiolabeled human SC could be competitively inhibited using unlabeled SC or secretory IgA but not with serum IgA or IgG. Immunoprecipitation and immunosorbent chromatography using human SC revealed the presence of a major component at 15 kDa in eosinophil extracts as well as in culture supernatants but not in neutrophils. The 15-kDa protein eluted from the human SC immunosorbent was able to bind to SC or to sIgA but not to serum IgA. Eosinophils preincubated with human SC or sIgA released eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO) after addition of anti-SC or anti-IgA monoclonal antibody as respective cross-linking reagents. These results indicated that binding of free or complexed SC to human eosinophils could induce eosinophil degranulation. Furthermore, the dose-dependent inhibition by SC of mediator release induced by sIgA but not by serum IgA, suggested that the receptor for SC could be involved in the preferential degranulation mediated by sIgA. These results indicate a novel pathway of eosinophil activation and its potential involvement in mucosal immunity, particularly in inflammatory diseases associated with infiltration of eosinophils and the enhanced production of sIgA.Keywords
This publication has 35 references indexed in Scilit:
- Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.The Journal of Experimental Medicine, 1992
- Heterogeneous expression of CD23 epitopes by eosinophils from patients. Relationships with IgE‐mediated functionsEuropean Journal of Immunology, 1991
- IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac diseaseClinical and Experimental Immunology, 1990
- The Second Receptor for IgE in Eosinophil Effector Function (Part 1 of 3)Published by S. Karger AG ,1989
- Circulating secretory component in breast neoplasms.Journal of Clinical Pathology, 1987
- Biosynthesis of the iga antibody receptor: A model for the transepithelial sorting of a membrane glycoproteinCell, 1984
- Fc receptors for IgA and other immunoglobulins on resident and activated alveolar macrophagesMolecular Immunology, 1983
- Heterogeneity of Human Peripheral Blood Eosinophils: Variability in Cell Density and Cytotoxic Ability in Relation to the Level and the Origin of HypereosinophiliaInternational Archives of Allergy and Immunology, 1983
- IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMAThe Lancet, 1982
- High serum levels of secretory IgA in liver diseaseDigestive Diseases and Sciences, 1982